The Pharmacology of Tapas, Part 1: The Silence We Keep
She teaches six days a week, adjusts with precision, and hasn’t missed a Mysore practice in three years. She’s also been on tirzepatide for eight months. She hasn’t told anyone. Not her teacher. Not her students. Not her practice partner who shares a cup of chai with her every Saturday. When someone compliments her “discipline” or asks about her “transformation,” she deflects to “clean eating” and “consistency.” The lie tastes like ash, but the alternative—admitting she’s on a GLP-1 agonist—feels impossible in a culture that treats pharmacological support as spiritual failure. She’s not alone. 🤫 The Substances We Don’t Discuss Across yoga studios and Mysore rooms, practitioners are quietly managing their bodies with tools they cannot name aloud: peptides for tendon healing, biologics for autoimmune…
